- Price
- $5.29
- Day
- +8.85%
- Mkt Cap
- $409.90M
- 52W Range
- $0.92 – $6.11
- Volume
- 2.03M
- Beta
- 0.19
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Alto Neuroscience maintains a 'Buy' rating, driven by the potential of ALTO-207 for treatment-resistant depression [TRD] and robust cash reserves. ALTO-207, a pramipexole/ondansetron combination, targets TRD with phase 2b topline data expected in 2H 2027 and possible phase 3 initiation by early 2027. Despite ALTO-100's phase 2b failure in MDD, ANRO's diversified pipeline and biomarker-driven strategies support continued optimism.
Read full article
Alto Ingredients is attractively valued, with strong multi-year earnings growth potential and a low forward PE ratio. ALTO benefits from favorable U.S. renewable fuel standards along with Section 45Q and 45Z tax credits. Operational improvements, including an 8% capacity increase at Pekin and expanded CO2 storage, support higher-margin growth and incremental tax credit eligibility.
Read full article
PEKIN, Ill., July 29, 2026 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO) a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, announced it will release its second quarter 2026 financial results after the close of market on Wednesday, August 5, 2026.
Read full article
ALTO and AMTX are pursuing distinct renewable fuel strategies as ethanol margins, tax credits and low-carbon initiatives shape their growth outlooks.
Read full article
ALTO is expanding premium CO2 sales while evaluating utilization and sequestration to unlock more value from ethanol byproducts.
Read full article
ALTO could gain from broader year-round E15 sales, which may lift ethanol demand as operations improve and 45Z credits support production.
Read full article
ALTO's strong rally reflects improving profitability, favorable market trends and growth initiatives, while its valuation remains attractive.
Read full article